Consequences of Nocturnal and Daytime Hypoxemia in COPD
Status:
Terminated
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
We will determine whether oxygen therapy lowers the level of substances in the blood which
cause inflammation, which is one of the adverse effects of COPD and whether oxygen improves
overall well being and quality of life as well as sleep quality.